2m 2m 2m 2m 2m 2m 2m
Biomarin Pharm (BMRN)
NASDAQ
$56.65+$1.44 (+2.61%)
Price as of Oct 22, 2026 7:30 PM EDT- $10.7BMarket Cap
- 3.45%1-Year Change
- BiotechnologyIndustry
Biomarin Pharm (BMRN)
$56.65+$1.44 (+2.61%)
BMRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $55.21 | ||
Change | -$1.23 (-2.18%) | ||
Open | $56.40 | ||
High | $57.00 | ||
Low | $54.91 | ||
Previous Close | $56.44 | ||
Volume | 2,506,314 | ||
30-Day Average Volume | 2,369,436 | ||
1-Week Change | 0.13% | ||
1-Month Change | -13.82% | ||
1-Year Change | 3.45% | ||
3-Year Change | -32.76% | ||
5-Year Change | -26.47% | ||
Fundamentals | |||
Shares Outstanding | 193.6M | ||
Total Assets | $11.7B | ||
Market Cap | $10.7B | ||
Enterprise Value | $14.0B | ||
Period: QTR TTM FY | |||
Revenue | $984.4M | ||
Net Income | $44.8M | ||
Free Cash Flow | $139.3M | ||
EBIT | $122.1M | ||
EBITDA | $219.8M | ||
Net Working Capital | $2.3B | ||
EPS | $0.23 | ||
Enterprise Value/EBITDA | 64 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 2 | ||
P/E | 240 | ||
PEG | -4 | ||
Price/Free Cash Flow | 77 | ||
Price/Operating Cash Flow | 64 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue